Annual CFO
-$9.57 M
+$9.24 M+49.11%
March 31, 2023
Summary
- As of March 6, 2025, MDNA annual cash flow from operations is -$9.57 million, with the most recent change of +$9.24 million (+49.11%) on March 31, 2023.
- During the last 3 years, MDNA annual CFO has fallen by -$5.50 million (-135.10%).
Performance
MDNA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$2.58 M
-$636.10 K-32.75%
June 30, 2023
Summary
- As of March 6, 2025, MDNA quarterly cash flow from operations is -$2.58 million, with the most recent change of -$636.10 thousand (-32.75%) on June 30, 2023.
- Over the past year, MDNA quarterly CFO has stayed the same.
Performance
MDNA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$10.35 M
-$773.50 K-8.08%
June 30, 2023
Summary
- As of March 6, 2025, MDNA TTM cash flow from operations is -$10.35 million, with the most recent change of -$773.50 thousand (-8.08%) on June 30, 2023.
- Over the past year, MDNA TTM CFO has stayed the same.
Performance
MDNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MDNA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +49.1% | 0.0% | 0.0% |
| 3 y3 years | -135.1% | 0.0% | 0.0% |
| 5 y5 years | -21.1% | 0.0% | 0.0% |
MDNA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.5% | +42.9% | +108.3% | +8.1% | +81.8% |
| 5 y | 5-year | +135.1% | +96.5% | +71.9% | +183.9% | +183.2% | +81.8% |
| alltime | all time | +387.8% | +96.5% | -279.9% | +183.9% | >+9999.0% | +81.8% |
Medicenna Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$2.58 M(+32.8%) | -$10.35 M(+8.1%) |
| Mar 2023 | -$9.57 M(-49.1%) | -$1.94 M(-22.1%) | -$9.57 M(-4.6%) |
| Dec 2022 | - | -$2.49 M(-25.2%) | -$10.03 M(-22.3%) |
| Sep 2022 | - | -$3.33 M(+84.7%) | -$12.91 M(-23.6%) |
| Jun 2022 | - | -$1.80 M(-24.8%) | -$16.89 M(-10.2%) |
| Mar 2022 | -$18.81 M(+62.3%) | -$2.40 M(-55.3%) | -$18.81 M(+5.0%) |
| Dec 2021 | - | -$5.37 M(-26.7%) | -$17.91 M(+13.3%) |
| Sep 2021 | - | -$7.32 M(+96.6%) | -$15.81 M(+16.9%) |
| Jun 2021 | - | -$3.72 M(+148.2%) | -$13.53 M(+16.7%) |
| Mar 2021 | -$11.59 M(+184.6%) | -$1.50 M(-54.1%) | -$11.59 M(-4.1%) |
| Dec 2020 | - | -$3.27 M(-35.0%) | -$12.08 M(+16.2%) |
| Sep 2020 | - | -$5.03 M(+181.6%) | -$10.39 M(+164.7%) |
| Jun 2020 | - | -$1.79 M(-10.2%) | -$3.93 M(-3.6%) |
| Mar 2020 | -$4.07 M | -$1.99 M(+25.7%) | -$4.07 M(+11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | -$1.58 M(-210.4%) | -$3.65 M(+1.2%) |
| Sep 2019 | - | $1.43 M(-174.1%) | -$3.61 M(-42.0%) |
| Jun 2019 | - | -$1.93 M(+23.0%) | -$6.22 M(+1.6%) |
| Mar 2019 | -$6.12 M(-22.6%) | -$1.57 M(+2.0%) | -$6.12 M(-10.6%) |
| Dec 2018 | - | -$1.54 M(+30.8%) | -$6.85 M(-11.6%) |
| Sep 2018 | - | -$1.18 M(-35.8%) | -$7.75 M(-7.7%) |
| Jun 2018 | - | -$1.83 M(-20.2%) | -$8.40 M(+6.3%) |
| Mar 2018 | -$7.91 M(+42.1%) | -$2.30 M(-5.9%) | -$7.91 M(+41.0%) |
| Dec 2017 | - | -$2.44 M(+33.7%) | -$5.61 M(+77.2%) |
| Sep 2017 | - | -$1.83 M(+36.7%) | -$3.17 M(+136.3%) |
| Jun 2017 | - | -$1.34 M(>+9900.0%) | -$1.34 M(+3343.4%) |
| Mar 2017 | -$5.56 M(+183.5%) | - | - |
| Sep 2016 | - | -$2000.00(-90.7%) | -$38.90 K(+5.4%) |
| Jun 2016 | - | -$21.60 K(+41.2%) | -$36.90 K(+141.2%) |
| Mar 2016 | -$1.96 M | -$15.30 K | -$15.30 K |
FAQ
- What is Medicenna Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Medicenna Therapeutics?
- What is Medicenna Therapeutics annual CFO year-on-year change?
- What is Medicenna Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Medicenna Therapeutics?
- What is Medicenna Therapeutics quarterly CFO year-on-year change?
- What is Medicenna Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Medicenna Therapeutics?
- What is Medicenna Therapeutics TTM CFO year-on-year change?
What is Medicenna Therapeutics annual cash flow from operations?
The current annual CFO of MDNA is -$9.57 M
What is the all time high annual CFO for Medicenna Therapeutics?
Medicenna Therapeutics all-time high annual cash flow from operations is -$1.96 M
What is Medicenna Therapeutics annual CFO year-on-year change?
Over the past year, MDNA annual cash flow from operations has changed by +$9.24 M (+49.11%)
What is Medicenna Therapeutics quarterly cash flow from operations?
The current quarterly CFO of MDNA is -$2.58 M
What is the all time high quarterly CFO for Medicenna Therapeutics?
Medicenna Therapeutics all-time high quarterly cash flow from operations is $1.43 M
What is Medicenna Therapeutics quarterly CFO year-on-year change?
Over the past year, MDNA quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Medicenna Therapeutics TTM cash flow from operations?
The current TTM CFO of MDNA is -$10.35 M
What is the all time high TTM CFO for Medicenna Therapeutics?
Medicenna Therapeutics all-time high TTM cash flow from operations is -$15.30 K
What is Medicenna Therapeutics TTM CFO year-on-year change?
Over the past year, MDNA TTM cash flow from operations has changed by $0.00 (0.00%)